Create a narrative

Oxford Biomedica Community

LSE:OXB Community

1 Narratives written by author
0 Comments on narratives written by author
18 Fair Values set on narratives written by author

Create a narrative

Oxford Biomedica

AN

AnalystConsensusTarget

Consensus Narrative from 6 Analysts

CDMO Expansion Will Widen Global Cell And Gene Therapy Access

Key Takeaways Expansion into AAV and other vector types reduces dependency risks and supports earnings growth through diversified revenue streams. Strategic initiatives and expanded operations within the cell and gene therapy market drive revenue growth and enhance market share opportunities.

UK£5.30

FV

44.2% undervalued

22.84%

Revenue growth p.a.

0

0

0

6 days ago